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There is insufficient epidemiological evidence on the relationship between 
autism spectrum disorder (ASD) and allergic diseases. We performed a 
cross-sectional survey to elucidate the associations between them using vali-
dated screening tools. The participants were children aged 3 - 6 years attend-
ing kindergarten or nursery school in Shika Town, Japan (n = 417; valid re-
sponse rate = 80.4%). Autism spectrum features were scored on the Social 
Communication Questionnaire (SCQ). Allergic symptoms (asthma, allergic 
rhinoconjunctivitis, and eczema) were determined according to the criteria of 
the International Study of Asthma and Allergies in Childhood. A total of 15 
children (4.5%) had an SCQ score of 11 points or higher. The prevalence of 
symptoms was 14.7% for asthma, and 5.3% for allergic rhinoconjunctivitis, 
and 11.4% for eczema. Logistic regression indicated that symptoms of eczema 
were significantly associated with SCQ scores of 11 points or higher [odds ra-
tio (OR), 4.38; 95% confidence interval (CI), 1.41 - 13.59]. The association 
persisted after adjustment for age, sex, and BMI (OR, 3.84; 95% CI, 1.20 - 
12.24). Moreover, asthmatic symptoms were significantly associated with male 
sex (OR, 2.09; 95% CI, 1.12 - 3.92) and overweight status (OR, 2.45; 95% CI, 
1.03 - 5.83). This suggests that higher SCQ scores, which imply more autism 
spectrum features, are associated with higher prevalence of eczema symptoms. 
While no causal relationships can be made, ASD might be associated with 
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Autism spectrum disorder (ASD) is a group of developmental disorders charac-
terized by both persistent deficits in social communication and social interaction 
across multiple contexts and restricted, repetitive patterns of behavior, interests, 
or activities [1]. The aforementioned symptoms must also be present in the early 
developmental period. On the other hand, allergies are hypersensitivity disorders 
of the immune system in which both innate and acquired immunities may con-
tribute to the development of allergic diseases (i.e., asthma, allergic rhinocon-
junctivitis and eczema) [2] [3]. Although the cause of ASD remains unknown in 
many cases [4], recent observational studies have demonstrated that allergic dis-
eases were more frequently seen in children with ASD compared to typically de-
veloping children, suggesting involvement of environmental factors in the de-
velopment of both diseases [5]-[10]. For example, our previous study [11] found 
a significant association between nasal allergy and high autism score using the 
Autism Screening Questionnaire (ASQ) among Japanese children aged 3 - 5 
years old [12]. An analysis of the National Health Insurance Database in Taiwan 
by Chen et al. revealed that atopic diathesis in early childhood elevated the fu-
ture risk of developing ASD [13]. A meta-analysis by Miyazaki et al. reported 
that there was a significantly higher estimated prevalence of asthma and allergic 
rhinoconjunctivitis in children with ASD compared to typically developing 
children [14]. However, in an American study, Jyonouchi et al. reported that an 
ASD group was not associated with atopic/non-atopic asthma, allergic rhinitis, 
and atopic dermatitis [5]. The controversial reports in the literature and limited 
epidemiological evidence therefore render the association between allergic dis-
ease and ASD unclear.  
Although the prevalence of ASD remains unknown in Japan due to the lack of 
large epidemiological studies, the prevalence of ASD is estimated to be on the 
increase all over the world [15]. It is estimated that the prevalence of ASD is 
about 1.5% of children in the U.S. [16], and 2% of children in the general popu-
lation in Korea [17]. The prevalence of allergic diseases has also increased rapid-
ly over the last few decades in developing countries, including Japan [18] [19]. 
Therefore, the concomitant increases of both ASD and allergic diseases represent 
a potentially important and unique public health burden.  
Until now, prevalence and risk factors for allergic diseases have been studied 
extensively in school age children but there is little information about younger 
children. Moreover, few epidemiological studies have examined the association 
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between allergic diseases and ASD, especially among younger children. Another 
limitation of the recent epidemiological studies on allergic diseases in ASD 
children is that they investigated diagnosed ASD only which is not necessarily 
ideal in epidemiological surveys for young children. It is estimated that ASD af-
fects approximately 2% of children in the general population and more than half 
of the cases are undiagnosed and untreated [17]. Moreover, in a Japanese na-
tionwide survey of adults with high-functioning ASD, they were first diagnosed 
at an average age of 10 years [20]. Thus, there is a high probability of missing 
possible ASD cases if employing only the diagnosed cases in surveying early 
childhood morbidity. In addition, comprehensive diagnostic assessment is often 
expensive and time-consuming work completed by a multidisciplinary team of 
professionals [21], and this can be stressful for children being assessed as well as 
their parents. Screening method improvements could thusly decrease the specific 
problem of diagnostic bias due to gaps in socioeconomic status or access to 
medical services [22] [23].  
In this paper, we describe the prevalence of symptoms of asthma, allergic rhi-
noconjunctivitis and eczema and clarify the association between allergic symp-
toms and autism spectrum features. Data were gathered with an epidemiological 
approach using validated screening tools in rural, Japanese, preschool-aged 
children (3 - 6 years). To assess autism spectrum features in these children, we 
used the Social Communication Questionnaire (SCQ) [24], formerly known as 
ASQ. For allergic diseases, we used a standardized questionnaire of the Interna-
tional Study of Asthma and Allergies in Childhood (ISAAC) [18] [19] [25] [26]. 
We hypothesized that the prevalence of allergic symptoms would be higher in 
children with autistic spectrum features than those without. We also investigated 
potential risk factors associated with allergic symptoms and ASD, including sex, 
age, and body mass index (BMI). These results could serve as guidelines for pre-
vention and treatment of allergic diseases in children with ASD. 
2. Materials and Methods 
2.1. Subjects and Sampling 
Our cross-sectional questionnaire-based survey was conducted in Shika Town, 
Ishikawa prefecture, Japan. Shika is a rural town located in the Noto peninsula 
with a total population of almost 22,500. The Shika study is an ongoing popula-
tion-based survey which aims to investigate the lifestyle and health status of the 
Japanese population [27] [28]. This survey was conducted from October to No-
vember, 2013. The self-administered questionnaires and envelops were distri-
buted for each child at all 7 preschools (1 kindergarten and 6 nursery schools) in 
the towns, with the parents then taking it home to be filled out. Prior to filling 
out the questionnaire, all participants in the study provided informed consent. 
The children’s parents completed the questionnaire. The number of children 
(n = 417) accounted for 99.0% of the total population of 3- to 6-year-old child-
ren in the town (n = 421) in 2013. The questionnaire was written in Japanese 
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and comprised questions about sex, age, height, weight, symptoms on allergic 
diseases and the SCQ. After completing the form, the questionnaires were taken 
back to the kindergartens and nursery schools for collection and returned to our 
university. In the returned 406 questionnaires, there is no missing data on va-
riables age, sex, height and weight. Regarding the SCQ, forms with more than 
four items missing were excluded from the statistical analysis (n = 61). Moreo-
ver, forms with missing data on allergic symptoms were excluded (n = 4), leav-
ing a total sample of 341 and a valid response rate of 81.8%. Of the 341 children 
analyzed, 46.6% were male (n = 159). Their age distribution was 11.7% for 
3-year-old (n = 40), 33.4% for 4-year-old (n = 114), 36.1% for 5-year-old (n = 
123), and 18.8% for 6-year-old (n = 64). A median age ± SD was 4.6 ± 0.9 years 
old. A mean ± SD height was 106.4 ± 7.4 cm, and a mean ± SD weight was 17.7 
± 3.3 kg. 
2.2. Screening Tool for ASD 
The SCQ lifetime Japanese version was used [24] [29]. It is a parent-report ques-
tionnaire designed to screen children who may need a more comprehensive 
evaluation because of possible ASD. It is composed of 38 items that assess spe-
cific ASD-related behaviors, such as communication with other children and 
nonverbal contact. It is based on the Autism Diagnostic Interview—Revised 
(ADI-R) algorithm [30], which is accepted as a standardized interview-based di-
agnostic instrument. The SCQ assesses the three core areas of functioning cha-
racteristic of youth with ASD; reciprocal social interaction, language and com-
munication, and repetitive and stereotyped patterns of behavior. The SCQ is one 
of the most widely used and studied screening instruments for identifying indi-
viduals at risk for ASD [31] [32] [33] [34] [35]. In the Japanese version, a ques-
tion on pronoun reversal is omitted because Japanese verbal language seldom 
uses a pronoun (i.e. “you” or “s/he”). Each item was rated on a two-point scale 
(0 = “no” and 1 = “yes”) and the range of possible scores is 0 to 38, with higher 
scores indicating more autistic symptomatology. Several clinical cutoff scores of 
the SCQ have been suggested so far (e.g. 11, 12, 15 or higher), and researchers 
appear to agree optimal cut-off score is dependent upon the context and nature 
of the study population. Among young children, a lower cut-off score is recom-
mended [31] [32] [36]. Thus, we categorized children into 2 groups: children 
with SCQ scores ≥ 11 as possible ASD cases and children with SCQ scores <11 as 
non-ASD cases. 
2.3. Measurement of Allergic Symptoms 
We used the Japanese version of the ISAAC written questionnaire for 6 - 7 year 
olds [37]. ISAAC is an international epidemiological research program estab-
lished in 1991 and formally closed in 2012. The questionnaire was originally de-
veloped to assess the worldwide prevalence of asthma, allergic rhinoconjunctivi-
tis and eczema among children aged 6 - 7 years in the general population and to 
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search possible risk factors that could affect allergic diseases. However, it is now 
used for younger children in multiple studies [38] [39] [40] [41] [42].  
Symptoms of asthma were estimated by positive answers to the following two 
questions: “Has your child ever had wheezing or whistling in the chest at any 
time in the past?” and “Has your child had wheezing or whistling in the chest in 
the past 12 months?” Affirmative answers to the following three questions were 
required to confirm the presence of symptoms of allergic rhinoconjunctivitis: 
“Has your child ever had a problem with sneezing, or a runny, or blocked nose 
when he/she did not have a cold or the flu?”, “In the last 12 months, has your 
child had a problem with sneezing, or a runny, or blocked nose when he/she did 
not have a cold or the flu?” and “In the past 12 months, has this nose problem 
been accompanied by itchy/watery eyes?”. Symptoms of eczema were defined as 
present in the case of positive responses to all the following three questions: 
“Has your child ever had an itchy rash which was coming and going for at least 
six months?”, “Has your child had this rash at any time in the past 12 months?” 
and “Has this itchy rash at any time affected any of the following places: the 
folds of the elbows, behind the knees, in front of the ankles, under the buttocks, 
or around the neck, ears, or eyes?”. 
2.4. Weight Abnormalities 
BMI was calculated as body weight in kilograms divided by height squared in 
meters. International age- and sex-specific cutoff points for BMI as defined by 
the International Obesity Task Force (IOTF) were used to define underweight, 
normal weight, and overweight [43] [44] [45]. These cutoff points are linked to 
the widely accepted adult BMI cutoff points of 18.5 for underweight, and 25 for 
overweight. Obesity was not defined in this study because of the small propor-
tion of obesity in Japanese children (i.e., 2.38% of boys and 2.49% of girls in 
2013) [46]. 
2.5. Statistical Analysis 
We evaluated differences between variables of interest within each of the three 
allergy symptoms, using chi-square or Fisher’s exact testing for categorical va-
riables (SCQ dichotomized by cutoff score, sex and categories of BMI), t-tests for 
continuous variables with normal distribution (age), and Mann-Whitney U tests 
for continuous variables with non-normal distribution (total SCQ score). We 
performed univariate logistic regression analyses to calculate the unadjusted 
odds ratios (OR) and the 95% confidence intervals (CI) and reported the crude 
association of variables with likelihood of each allergic symptom (positive = 1, 
negative = 0). Furthermore, we performed forced entry methods of three separated 
multivariate logistic regression analyses. All statistical tests were two-tailed. P 
values less than 0.05 were regarded as indicating statistical significance. IBM 
SPSS for Windows, Version 22.0 (IBM Corp., Armonk, NY, USA) was used for 
all statistical analyses. 
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2.6. Ethical Approval 
We obtained informed consent for study participation from the parents. All 
procedures performed in studies involving human participants were in accor-
dance with the ethical standards of both institutional and national research 
committees and with the 1964 Helsinki declaration and its later amendments or 
comparable ethical standards. Ethical approval to conduct the present study was 
received from the Kanazawa University Medical Research Ethics Committee 
(reference number: 1464). 
3. Results 
Figure 1 demonstrates the range and distribution of the total SCQ scores of the 
341 children. The data had a range of 0–20, with a mean (standard error: SE) of 
3.66 (0.19). The distribution was not normal, and was skewed to the right 
(skewness = 1.67, kurtosis = 3.48). In the present sample, 15 children (4.5%) had 
SCQ scores ≥ 11. 
Table 1 summarizes the characteristics of children, classified by each allergic 
symptom. A total of 50 (14.7%) children reported a symptom of asthma, 18 
(5.3%) reported a symptom of allergic rhinoconjunctivitis, and 39 (11.4%) re-
ported a symptom of eczema. Compared to girls, boys were significantly more 
likely to have a symptom of asthma (p = 0.018). The prevalence of a symptom of 
eczema was 33.3% for children with SCQ score ≥ 11% and 10.4% for children 
with SCQ score < 11 with this difference showing statistical significance (p = 
0.019). We performed post hoc test and revealed the statistical power (1-β) was 
0.63. There were no statistically significant differences within total SCQ score 
age and BMI categories between two groups divided by allergic symptoms.  
ORs and 95% CIs for symptom of asthma, rhinoconjunctivitis and eczema  
 
 
Figure 1. The range and distribution of total SCQ scores among children aged 3 - 6 years 
in Shika Town (n = 341).  
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Table 1. Characteristics of the children stratified by positive symptoms of asthma, rhinoconjunctivitis, and eczema (n = 341). 
 Asthma symptom Allergic rhinoconjunctivitis symptom Eczema symptom 
 Positive Negative p value Positive Negative p value Positive Negative p value 
 50 (14.7%) 291 (85.3%)  18 (5.3%) 323 (94.7%)  39 (11.4%) 302 (88.6%)  
SCQ score, mean (SE)  
Continuous 4.03 (0.52) 3.61 (0.21) 0.412a 4.89 (1.02) 3.60 (0.19)a 0.161a 4.71 (0.84) 3.54 (0.19) 0.671a 
SCQ score, n (%)  
11 or higher 3 (20.0%) 12 (80.0%) 0.469b 2 (15.4%) 13 (84.6%) 0.184b 5 (33.3%) 10 (66.7%) 0.019b 
Under 11 47 (14.4%) 279 (85.6%)  16 (4.9%) 310 (95.1%)  34 (10.4%) 292 (89.6%)  
Age, mean ± SD  
Continuous 4.70 ± 0.91 4.60 ± 0.92 0.500c 4.56 ± 0.71 4.62 ± 0.93 0.765c 4.41 ± 0.88 4.65 ± 0.92 0.133c 
Gender, n (%)  
Boy 31 (19.5%) 128 (80.5%) 0.018d 10 (6.3%) 149 (93.7%) 0.435d 19 (11.9%) 140 (88.1%) 0.781d 
Girl 19 (10.4%) 163 (89.6%)  8 (4.4%) 174 (95.6%)  20 (11.0%) 162 (89.0%)  
BMI, n (%)  
Underweight 8 (14.5%) 47 (85.5%) 0.144d 2 (3.6%) 53 (96.4%) 0.779b 9 (21.1%) 46 (15.1%) 0.448d 
Normal weight 33 (13.1%) 218 (86.9%)  15 (6.0%) 236 (94.0%)  26 (68.4%) 225 (74.9%)  
Overweight 9 (25.7%) 26 (74.3%)  1 (2.9%) 34 (97.1%)  4 (11.4%) 31 (88.6%)  
SCQ: Social Communication Questionnaire; SE: standard error; SD: standard deviation; BMI: body mass index. a. Mann-Whitney U test; b. Fisher's exact 
test; c. T test; d. Chi square test. 
 





 OR 95%CI p value OR 95%CI p value 
SCQ score (vs Under 11)       
11 or higher 1.46 (0.40 - 5.38) 0.567 1.26 (0.32 - 4.87) 0.741 
Age       
Continuous 1.12 (0.81 - 1.56) 0.490 1.07 (0.76 - 1.49) 0.709 
Gender (vs Girl)       
Boy 2.06 (1.11 - 3.81) 0.022 2.09 (1.12 - 3.92) 0.021 
BMI (vs Normal Weight)       
Underweight 1.17 (0.51 - 2.70) 0.714 1.11 (0.48 - 2.60) 0.808 
Overweight 2.37 (1.02 - 5.51) 0.046 2.45 (1.03 - 5.83) 0.043 
OR: odds ratio; CI: confidence interval: SCQ: Social Communication Questionnaire; BMI: Body mass index. 
 
corresponding to other variables are shown in Tables 2-4, respectively. In the 
crude model, children with an SCQ score of 11 points or higher were more likely 
to have eczema compared to other children (OR = 4.38; 95 % CI = 1.41 - 13.59;  
D. Hori et al. 
 
 
DOI: 10.4236/health.2017.98089 1242 Health 
 
Table 3. Results of logistic regressions on positive symptoms of rhinoconjunctivitis by 




 OR 95% CI p value OR 95% CI p value 
SCQ score (vs Under 11)       
11 or higher 2.94 (0.61 - 14.16) 0.178 3.32 (0.66 - 16.72) 0.146 
Age       
Continuous 0.93 (0.55 - 1.55) 0.770 0.94 (0.56 - 1.58) 0.805 
Gender (vs Girl)       
Boy 1.44 (0.56 - 3.76) 0.451 1.47 (0.56 - 3.85) 0.439 
BMI (vs Normal Weight)       
Underweight 0.61 (0.14 - 2.77) 0.526 0.54 (0.12 - 2.49) 0.427 
Overweight 0.48 (0.06 - 3.71) 0.478 0.43 (0.05 - 3.45) 0.425 
OR: odds ratio; CI: confidence interval: SCQ: Social Communication Questionnaire; BMI: body mass index. 
 





 OR 95% CI p value OR 95% CI p value 
SCQ score (vs Under 11)       
11 or higher 4.38 (1.41 - 13.59) 0.011 3.84 (1.20 - 12.24) 0.023 
Age       
Continuous 0.74 (0.51 - 1.08) 0.115 0.77 (0.53 - 1.12) 0.171 
Gender (vs Girl)       
Boy 1.15 (0.59 - 2.26) 0.683 1.17 (0.59 - 2.34) 0.655 
BMI (vs Normal Weight)       
Underweight 1.53 (0.65 - 3.60) 0.328 1.35 (0.56 - 3.25) 0.504 
Overweight 1.15 (0.38 - 3.52) 0.808 1.06 (0.34 - 3.38) 0.916 
OR: odds ratio; CI: confidence interval: SCQ: Social Communication Questionnaire; BMI: body mass index. 
 
p = 0.011) (Table 4). When the model was adjusted for age, sex and BMI catego-
ries, the association remained statistically significant (OR = 3.84; 95% CI = 1.20 - 
12.24; p = 0.023). In the adjusted model, being male (OR = 2.09; 95% CI = 1.12 - 
3.92; p = 0.021) and overweight (OR = 2.45; 95% CI = 1.03 - 5.83; p = 0.043) 
were shown to be statistically significantly related to asthma (Table 2). Overall, 
allergic rhinoconjunctivitis was not associated with SCQ classification, age, sex, 
and weight abnormalities. 
4. Discussion 
In 2013, we examined the prevalence of asthma, allergic rhinoconjunctivitis and 
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eczema among children in kindergarten and nursery schools in Shika Town, Ja-
pan. Furthermore, we found that preschool-aged children with autism spectrum 
features had an increased likelihood of suffering from symptom of eczema. A 
statistically significant association persisted after adjusting for age, sex, and BMI 
categories. To our knowledge, this is the first study using validated screening 
measures that shows a higher prevalence of eczema symptoms in children aged 3 - 
6 years with autism spectrum features compared to those without. This seminal 
result may be due to the effective simplicity of screening tools such as the ISAAC 
questionnaire and SCQ. While the cross-sectional nature of the study makes a 
causal conclusion impossible, the theory that autism spectrum traits would be 
related to eczema is supported. In contrast, we did not confirm any results from 
recent studies which suggest that asthma or allergic rhinoconjunctivitis are asso-
ciated with ASD.  
Among the participants analyzed, 4.4% (n = 15) were presumed to have ASD 
suggesting that some cases with SCQ scores ≥ 11 were false positives. We recog-
nized that the SCQ could not be a replacement for a clinician-verified diagnosis 
and we acknowledge, as illustrated in Figure 1, that it is difficult to clearly dis-
tinguish possible ASD cases from others by screening tools. However, Sivertsen 
et al. employed the Autism Spectrum Screening Questionnaire in their study and 
argued that a strict categorical diagnosis would not be useful in epidemiological 
studies because ASD is a spectrum problem [47]. Johnson et al. pointed out that 
children with false positive screens are a high risk group for other neuro-cognitive 
and behavioral impairments and further assessment would be beneficial [48]. 
Thus, we considered that the prevalence subsumed borderline ASD cases, not 
implying a marked overestimate. The identification of undiagnosed and un-
treated ASD is important, with the potential to help parents increase knowledge 
of ASD and improve interaction with their children from earlier ages [49].  
Epidemiological study of allergic symptoms using the ISAAC questionnaire 
among Japanese preschool age children is scarce in the literature. We compared 
the present results from Shika Town (asthma, allergic rhinoconjunctivitis, ecze-
ma; 14.7%, 5.3%, 11.4%) with those obtained using the same questionnaire in the 
Ogasawara Islands, and Setagaya, Japan. The prevalence of asthma symptoms 
found in this study was higher than the study of preschool children conducted in 
the Ogasawara Islands (asthma, 12.2%) [50]. The prevalence of three allergic 
disease symptoms found in this study was lower than in the study of 6-year-old 
school children conducted in Setagaya (asthma, allergic rhinoconjunctivitis, ec-
zema; 18.2%, 19.7%, 19.6%) [51]. It is well known that asthma is more prevalent 
in urbanized areas as air pollution is one of the environmental factors that can 
exacerbate asthma. Differences in pollution levels might explain why the preva-
lence of current wheezing in Shika Town was higher than the Ogasawara Islands 
(less populated area) and lesser than Setagaya (one of the most populated area in 
Japan).  
The prevalence of allergic rhinoconjunctivitis was only 5.3% in this study. The 
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prevalence of allergic rhinoconjunctivitis in general population is reported to be 
more than 10% in recent studies of school children in developed countries [18]. 
Allergic rhinoconjunctivitis generally develops with gradual aeroallergen sensi-
tization with seasonal allergens, mainly with cedar pollen or house dust mites in 
Japan [52]. Its prevalence peaked at 10 years old [51]. Therefore, the low preva-
lence of allergic rhinoconjunctivitis in this study is plausible.  
Our findings are consistent with recent studies that found eczema was signifi-
cantly more prevalent in children with ASD compared to children without ASD 
[13] [53] [54]. We could not find significant associations of autism spectrum 
features with asthma or allergic rhinoconjunctivitis. At present, explanations for 
the mechanisms driving the high prevalence of allergic diseases in children with 
ASD remain speculative. One possible explanation is that eczema symptoms af-
fected SCQ total scores because the SCQ is a scale that assesses not only social 
interaction and communication but also behavioral symptoms. The discomfort 
and pain associated with allergic diseases would aggravate behavioral symptoms 
in children with ASD [55]. Jyonouchi pointed out that eczema tends to be un-
derdiagnosed in ASD children because symptoms could be masked by associated 
behavioral problems [5]. Due to the cross-sectional design of our study, a 
cause-effect relationship between allergic symptoms and high SCQ score could 
not be determined. A future longitudinal study is therefore required to address 
this issue.  
It should also be noted that our results suggested a significant association be-
tween obesity and asthmatic symptoms. The result is consistent with survey in 
Japan [56] and a meta-analysis of prospective epidemiological studies by Beuther 
and Sutherland showing a higher prevalence of asthma in overweight/obese 
people [57]. It is also well known that asthma is more likely to occur in boys 
compared to girls [58]. ASD has the same tendency as asthma in regard to 
weight abnormalities and sex: ASD is often associated with obesity and more 
prevalent in boys [39] [59] [60] [61] [62]. However, there are few studies inves-
tigating ASD and BMI in Japan. By investigating the differences in BMI and sex 
more deeply it might elucidate the cause(s) of ASD.  
This study had methodological strengths. Study subjects were homogeneous 
with the same residential background. We realized a high valid response rate 
(81.8%), surveyed 99% of the whole area population and minimized selection 
bias. The definitions of asthma, allergic rhinoconjunctivitis, and eczema were 
based on the ISAAC questionnaire which has been validated and used world-
wide, however, it should be noted that wheezing in young children is not neces-
sarily caused by allergies [63]. The definition of BMI categories were based on 
IOTF (now known as World Obesity) guidelines. Although a study in Belgium 
showed the inaccuracy of parentally reported weight and height for classifying 
preschool-aged children into BMI categories [64], in Japan, physical measure-
ments are generally carried out monthly at preschools. Thus, we consider the 
BMI values in this study to be precise.  
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Limitations of the present study other than mentioned above need to be 
noted. First, the main limitation of our study is the sample size of 417 children, 
which might not be large enough to identify significant differences of allergic 
symptoms between children with possible ASD and those without. The relatively 
small number of children with SCQ score ≥ 11 suggests type II error, which re-
stricts the power to detect relevant predictors. A careful interpretation of our 
findings is required in light of this. Future investigations with a larger sample 
could reveal significant relationships among allergic diseases and ASD. Second, 
we could not measure all variables that are likely to be a confounder in the asso-
ciation between allergic diseases and ASD (e.g. maternal status in pregnancy, or 
dietary habit). Third, we could not collect data from children who did not go to 
preschools. Children with severe behavioral problems might have been refused 
admission. Fourth, there is seasonal variation in reporting of allergic symptoms 
even though the questions asked about symptoms during the past year [65]. Fi-
nally, the extrapolation of conclusions from our study to other ethnicities/ 
cultures is limited by the fact that the participants were ethnically and culturally 
homogeneous. 
5. Conclusion 
Despite these limitations, this is the first study that used validated screening 
tools to assess the association between ASD and allergic symptoms in a general 
Japanese early childhood population. The study adds evidence that young child-
ren with possible ASD are more likely have eczema symptoms compared to oth-
ers. These seminal results offer important clues to environmental influences on 
ASD and allergic diseases. Future studies using larger samples with a longitudin-
al design are needed to better characterize the causal association between ASD 
and allergic diseases. 
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